{"title":"The evaluation of suppliers for public pharmaceutical laboratories: regulatory and legal implications","authors":"Driele Neves, C. Silva, F. Silva, B. Barreto","doi":"10.35259/isi.sact.2019_32776","DOIUrl":null,"url":null,"abstract":"Introduction: Suppliers have a very important relevance in the supply chain. As a public institution, Bio-Manguinhos Institute is submitted to the implementation law’s which operate the public purchasing process for the acquisition of its raw materials, which includes but not limited to the Laws n° 8.666/93 and n° 10.520/02 . In addition, as a pharmaceutical manufacturer industry, it is also included in Resolution RDC n° 17, of April 16, 2010 of the National Agency of Sanitary Surveillance (ANVISA). The fact that to comply with the various applicable laws, it becomes a challenge for the supply area, since it must meet customer expectations and chain interfaces, whether internal or external.","PeriodicalId":427855,"journal":{"name":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","volume":"130 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anais do IV International Symposium on Immunobiological e VII Seminário Anual Científico e Tecnológico de Bio-Manguinhos","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35259/isi.sact.2019_32776","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Suppliers have a very important relevance in the supply chain. As a public institution, Bio-Manguinhos Institute is submitted to the implementation law’s which operate the public purchasing process for the acquisition of its raw materials, which includes but not limited to the Laws n° 8.666/93 and n° 10.520/02 . In addition, as a pharmaceutical manufacturer industry, it is also included in Resolution RDC n° 17, of April 16, 2010 of the National Agency of Sanitary Surveillance (ANVISA). The fact that to comply with the various applicable laws, it becomes a challenge for the supply area, since it must meet customer expectations and chain interfaces, whether internal or external.